1. Home
  2. SOPA vs VRAX Comparison

SOPA vs VRAX Comparison

Compare SOPA & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOPA
  • VRAX
  • Stock Information
  • Founded
  • SOPA 2018
  • VRAX 2013
  • Country
  • SOPA Singapore
  • VRAX United Kingdom
  • Employees
  • SOPA N/A
  • VRAX N/A
  • Industry
  • SOPA EDP Services
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • SOPA Technology
  • VRAX Health Care
  • Exchange
  • SOPA Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • SOPA 3.8M
  • VRAX 4.4M
  • IPO Year
  • SOPA 2021
  • VRAX 2022
  • Fundamental
  • Price
  • SOPA $1.25
  • VRAX $0.99
  • Analyst Decision
  • SOPA Strong Buy
  • VRAX Strong Buy
  • Analyst Count
  • SOPA 1
  • VRAX 1
  • Target Price
  • SOPA $15.00
  • VRAX $3.00
  • AVG Volume (30 Days)
  • SOPA 106.3K
  • VRAX 149.4K
  • Earning Date
  • SOPA 08-18-2025
  • VRAX 02-05-2025
  • Dividend Yield
  • SOPA N/A
  • VRAX N/A
  • EPS Growth
  • SOPA N/A
  • VRAX N/A
  • EPS
  • SOPA N/A
  • VRAX N/A
  • Revenue
  • SOPA $6,731,955.00
  • VRAX $6,331.00
  • Revenue This Year
  • SOPA N/A
  • VRAX $217,274.83
  • Revenue Next Year
  • SOPA $45.16
  • VRAX N/A
  • P/E Ratio
  • SOPA N/A
  • VRAX N/A
  • Revenue Growth
  • SOPA N/A
  • VRAX N/A
  • 52 Week Low
  • SOPA $0.64
  • VRAX $0.74
  • 52 Week High
  • SOPA $6.75
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • SOPA 47.70
  • VRAX 55.13
  • Support Level
  • SOPA $1.23
  • VRAX $0.86
  • Resistance Level
  • SOPA $1.35
  • VRAX $1.10
  • Average True Range (ATR)
  • SOPA 0.06
  • VRAX 0.10
  • MACD
  • SOPA -0.00
  • VRAX 0.02
  • Stochastic Oscillator
  • SOPA 45.45
  • VRAX 47.90

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

Share on Social Networks: